A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand

BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is the only curative treatment available to severe thalassemic patients. The treatment, however, is very costly, particularly in the context of low and middle income countries, and no studies have been carried out to explore its economic jus...

Descripción completa

Detalles Bibliográficos
Autores principales: Leelahavarong, Pattara, Chaikledkaew, Usa, Hongeng, Suradej, Kasemsup, Vijj, Lubell, Yoel, Teerawattananon, Yot
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914036/
https://www.ncbi.nlm.nih.gov/pubmed/20633303
http://dx.doi.org/10.1186/1472-6963-10-209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914036/
https://www.ncbi.nlm.nih.gov/pubmed/20633303
http://dx.doi.org/10.1186/1472-6963-10-209

Ejemplares similares